Minimal change disease associated with newly diagnosed mantle cell lymphoma

8Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Mantle cell lymphoma (MCL) is a rare but aggressive form of non-Hodgkin's lymphoma. Involvement of the kidney is an infrequent occurrence in patients with MCL and can be the result of direct infiltration or paraneoplastic glomerulopathy. Proliferative glomerulonephritis, membranoproliferative glomerulonephritis and focal segmental glomerulosclerosis have previously been reported in association with MCL. We report a 55-year-old woman who developed nephrotic syndrome due to biopsy proven minimal change disease (MCD) in association with MCL. Proteinuria decreased with prednisolone treatment and MCD remains in remission without any immunosuppressant after the treatment of the underlying MCL. © 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted.

Cite

CITATION STYLE

APA

Khow, K. S. F., Yong, A. S. M., Yong, T. Y., Kuss, B. J., Barbara, J. A. J., & Li, J. Y. Z. (2014). Minimal change disease associated with newly diagnosed mantle cell lymphoma. Renal Failure, 36(4), 634–637. https://doi.org/10.3109/0886022X.2014.883905

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free